Li et al. reported that programmed death ligand-1 (PD-L1) promotes primary resistance of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIs, potentially by inducing autophagy via the MAPK signaling pathway (Li N. et al., 2024). Here, EGFR is linked to lung adenocarcinoma.